Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies DOI
Sanne de Wit, Claire Glen, Rudolf A. de Boer

и другие.

Cardiovascular Research, Год журнала: 2022, Номер 118(18), С. 3451 - 3466

Опубликована: Авг. 24, 2022

Heart failure (HF) and cancer are the leading causes of death worldwide accumulating evidence demonstrates that HF affect one another in a bidirectional way. Patients with at increased risk for developing cancer, is associated accelerated tumour growth. The presence malignancy may induce systemic metabolic, inflammatory, microbial alterations resulting impaired cardiac function. In addition to pathophysiologic mechanisms shared between HF, overlaps also exist pathways required normal physiology Therefore, these explain cardiotoxicity as result targeted anti-cancer therapies. This review provides an overview involved connection specifically focusing upon current 'hot-topics' mechanisms. It subsequently describes therapies cardiotoxic potential overlap their targets

Язык: Английский

F. Nucleatum enhances oral squamous cell carcinoma proliferation via E-cadherin/β-Catenin pathway DOI Creative Commons
Zhengrui Li, Yuan Liu, Xufeng Huang

и другие.

BMC Oral Health, Год журнала: 2024, Номер 24(1)

Опубликована: Май 2, 2024

Abstract Background Fusobacterium nucleatum ( F. ) is a microbial risk factor whose presence increases the of oral squamous cell carcinoma (OSCC) progression. However, whether it can promote proliferation OSCC cells remains unknown. Methods In this study, we investigated effect on using in vitro and vivo experiments. Results Our results showed that promoted proliferation, doubling count after 72 h (CCK-8 assay). Cell cycle analysis revealed G2/M phase arrest. interaction with CDH1 triggered phosphorylation, upregulating downstream protein β-catenin activating cyclinD1 Myc. Notably, did not affect noncancerous cells, unrelated to expression levels CAL27 cells. Overexpression phosphorylated 293T upregulate cycle-related genes. BALB/c nude experiments increased tumor volume Ki-67 index intervention. Conclusion study suggests promotes through CDH1/β-catenin pathway, advancing our understanding its role progression highlighting potential as therapeutic target.

Язык: Английский

Процитировано

7

Unraveling the complexities of colorectal cancer and its promising therapies – An updated review DOI

Sayan Saha,

Shreya Ghosh, Suman Ghosh

и другие.

International Immunopharmacology, Год журнала: 2024, Номер 143, С. 113325 - 113325

Опубликована: Окт. 14, 2024

Язык: Английский

Процитировано

7

Bacteriome and mycobiome dysbiosis in oral mucosal dysplasia and oral cancer DOI Creative Commons
Georgios N. Belibasakis,

Chaminda Jayampath Seneviratne,

Ruwan Duminda Jayasinghe

и другие.

Periodontology 2000, Год журнала: 2024, Номер 96(1), С. 95 - 111

Опубликована: Март 19, 2024

Abstract It has long been considered that the oral microbiome is tightly connected to health and dysbiotic changes can be detrimental occurrence progression of dysplastic mucosal lesions or cancer. Improved understanding concepts microbial dysbiosis together with advances in high‐throughput molecular sequencing these pathologies have charted greater microbiological detail nature their clinical state. This review discusses bacteriome mycobiome associated lesions, candidiasis, squamous cell carcinoma, aiming delineate information available date pursuit advancing diagnostic prognostic utilities for medicine.

Язык: Английский

Процитировано

6

The Impact of Oral Microbiome Dysbiosis on the Aetiology, Pathogenesis, and Development of Oral Cancer DOI Open Access
Jasminka Talapko,

Suzana Erić,

Tomislav Meštrović

и другие.

Cancers, Год журнала: 2024, Номер 16(17), С. 2997 - 2997

Опубликована: Авг. 28, 2024

Oral squamous cell carcinoma (OSCC) is the most common head and neck cancer. Although oral cavity an easily accessible area for visual examination, OSCC more often detected at advanced stage. The global prevalence of around 6%, with increasing trends posing a significant health problem due to increase in morbidity mortality. microbiome has been target numerous studies, findings highlighting role dysbiosis developing OSCC. Dysbiosis can significantly pathobionts (bacteria, viruses, fungi, parasites) that trigger inflammation through their virulence pathogenicity factors. In contrast, chronic bacterial contributes development Pathobionts also have other effects, such as impact on immune system, which alter responses contribute pro-inflammatory environment. Poor hygiene carbohydrate-rich foods risk factors mechanisms are not yet fully understood remain frequent research topic. For this reason, narrative review concentrates issue potential cause OSCC, well underlying involved.

Язык: Английский

Процитировано

6

Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies DOI
Sanne de Wit, Claire Glen, Rudolf A. de Boer

и другие.

Cardiovascular Research, Год журнала: 2022, Номер 118(18), С. 3451 - 3466

Опубликована: Авг. 24, 2022

Heart failure (HF) and cancer are the leading causes of death worldwide accumulating evidence demonstrates that HF affect one another in a bidirectional way. Patients with at increased risk for developing cancer, is associated accelerated tumour growth. The presence malignancy may induce systemic metabolic, inflammatory, microbial alterations resulting impaired cardiac function. In addition to pathophysiologic mechanisms shared between HF, overlaps also exist pathways required normal physiology Therefore, these explain cardiotoxicity as result targeted anti-cancer therapies. This review provides an overview involved connection specifically focusing upon current 'hot-topics' mechanisms. It subsequently describes therapies cardiotoxic potential overlap their targets

Язык: Английский

Процитировано

27